Comparison
2p21 Microdeletion Syndrome Without Cystinuria C4749458 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 2p21 Microdeletion Syndrome Without Cystinuria and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
2p21 Microdeletion Syndrome Without Cystinuria C4749458
A chromosomal deletion on chromosome 2 involving some genes shared with another condition but without the kidney component. Supportive care addresses each person's specific needs.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
2p21 Microdeletion Syndrome Without Cystinuria C4749458
0-null
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
2p21 Microdeletion Syndrome Without Cystinuria C4749458
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome Without Cystinuria C4749458
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome Without Cystinuria C4749458
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
2p21 Microdeletion Syndrome Without Cystinuria C4749458
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
2p21 Microdeletion Syndrome Without Cystinuria C4749458
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
2p21-microdeletion-syndrome-without-cystinuria-C4749458 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p21 Microdeletion Syndrome Without Cystinuria C4749458 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Developmental delay | Not established in the supplied description. | May occur, but features vary. | Moderate |
| Kidney or cystinuria features | Described as lacking the kidney component. | No kidney finding is supplied. | Moderate |
| Overall clinical severity | Labeled severe, but individual needs vary. | Labeled moderate, with variable features. | Low |
When to favor each condition
Choose 2p21 Microdeletion Syndrome Without Cystinuria C4749458 when
A confirmed deletion involves 2p21.
The chromosomal location supports this interpretation.
High
Cystinuria or the kidney component is absent.
This matches the stated distinction from a related condition.
Moderate
Support needs appear substantial.
The source labels severity as severe, but this is not diagnostic alone.
Low
Choose 14q11 2 Microduplication Syndrome C4749855 when
Testing shows extra material at 14q11.2.
The duplication location distinguishes it from a 2p21 deletion.
High
Developmental delay begins in early childhood.
The supplied onset range is 0–5 years, although features vary.
Moderate
No 2p21 deletion is identified.
Absence of one finding does not prove the other condition.
Low
How key tests differ
| Test | 2p21 Microdeletion Syndrome Without Cystinuria C4749458 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a 2p21 deletion. | May identify a 14q11.2 duplication. | The genomic result, not symptoms alone, distinguishes them. |
| Targeted genetic confirmation | Confirms deletion extent when clinically indicated. | Confirms duplication extent when clinically indicated. | A clinician should interpret breakpoints and gene content. |
| Kidney evaluation | Kidney component is described as absent, but assessment follows clinical need. | No specific kidney expectation is supplied. | An abnormal result is not itself either diagnosis. |
Prognosis comparison
2p21 Microdeletion Syndrome Without Cystinuria C4749458
- Outcome
- Long-term outcome is not established by the supplied data.
- Factors
- Deletion extent, affected functions, and support needs may matter.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Outcome is variable and not precisely established here.
- Factors
- Duplication content, developmental needs, and monitoring may matter.
Time frame: Both are described as chronic; exact timelines are unavailable.
Clinician interpretation of the genetic report and individual findings is required.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Specific complications are not established here. Developmental delay may require support. Needs should be assessed individually. |
| Kidney involvement | The named syndrome excludes the cystinuria component. Kidney involvement is not described in the source. Do not infer kidney disease from either label alone. |
| Long-term medical complexity | Labeled severe and chronic. Labeled moderate and chronic. These labels do not establish exact outcomes. |
Patient education highlights
- HighGenetic confirmation
Ask which chromosomal change was found and what it means for care.
- HighSupportive care
Management is individualized and may include therapies and monitoring.
- MediumVariable features
Reported features differ, so another person’s course may not predict yours.